Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 15Lung Neoplasms 7Nasopharyngeal Carcinoma 6Colorectal Neoplasms 4Breast Neoplasms 3Uterine Cervical Neoplasms 2Melanoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Esophageal Neoplasms 2Stomach Neoplasms 1Sarcoma 1Recurrence 1Radiation Injuries 1Quality of Life 1Osteosarcoma 1Non-squamous Non-small Cell Lung Cancer 1Neuroblastoma 1Nasopharyngeal Neoplasms 1Head and Neck Neoplasms 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Brain Neoplasms 1Advanced Pancreatic Cancer 1Advanced Colorectal Cancer 1Adenocarcinoma of Lung 1

Interventions

Drug Therapy 4apatinib 3Oxaliplatin 3pemigatinib 2pembrolizumab 2cemiplimab 2avelumab 2atezolizumab 2S 1 (combination) 2Nivolumab 2Leucovorin 2Irinotecan 2Folfox protocol 2Fluorouracil 2Everolimus 2Erlotinib Hydrochloride 2Endoscopic Mucosal Resection 2Docetaxel 2Capecitabine 2CGX1321 2vandetanib 1titanium silicide 1tepotinib 1tegafur-gimeracil-oteracil 1talazoparib 1sodium thiosulfate 1selpercatinib 1rucaparib 1pralsetinib 1ponatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gastrointestinal Neoplasms × endostar protein × Clear all
NCT06301828 2024-03-08

Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

Nanjing First Hospital, Nanjing Medical University

Phase 2 Unknown
16 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡